Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.
about
Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based studyIncidence of Campylobacter and Salmonella infections following first prescription for PPI: a cohort study using routine data.Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies.Factors associated with the initiation of proton pump inhibitors in corticosteroid users.Adverse effects of long-term proton pump inhibitor therapy.Effects of proton pump inhibitors on lung cancer precise radiotherapy-induced radiation pneumonitisRisk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis.Proton pump inhibitors: Risks of long-term use.Population-based cohort study on the risk of pneumonia in patients with non-traumatic intracranial haemorrhage who use proton pump inhibitors.Proton pump inhibitor-associated pneumonia: Not a breath of fresh air after all?Use of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case-control study.Frequency and time to onset of community-acquired respiratory tract infections in patients receiving esomeprazole: a retrospective analysis of patient-level data in placebo-controlled studies.The impact of acid-suppressing drugs to the patients with chronic obstructive pulmonary disease: A nationwide, population-based, cohort study.Risk of community-acquired pneumonia in patients with a diagnosis of pernicious anemia: a population-based retrospective cohort study.Risk of Stroke-Associated Pneumonia With Acid-Suppressive Drugs: A Population-Based Cohort Study.Year in review: medication mishaps in the elderly.Angiotensin-converting enzyme inhibitor use and pneumonia risk in community-dwelling older adults: results from a population-based case-control study.Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis.A new strategy with proton pump inhibitors for the prevention of acute exacerbations in COPD.Prescribing proton pump inhibitors: is it time to pause and rethink?Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis.Indications and safety of proton pump inhibitor drug use in patients with cancer.Anticholinergic medications and risk of community-acquired pneumonia in elderly adults: a population-based case-control study.Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence.Pharmacogenomic testing: the case for CYP2C19 proton pump inhibitor gene-drug pairs.An interprofessional approach to reducing the overutilization of stress ulcer prophylaxis in adult medical and surgical intensive care units.Reply to: Proton Pump Inhibitors and Risk of Pneumonia in Individuals with Dementia.
P2860
Q28595726-975C766F-AF60-469F-B9B2-40E194ED21EDQ30616899-E17E938A-8440-4F1B-8475-3D9042EF4D81Q30928614-CD8ED39C-AF7D-4B95-BDC2-ADF21ABAEB64Q34141425-99552699-3B32-47AC-BCB0-67BBC9BCF239Q34167899-A4BEB903-0A29-49F1-A49D-CE69156101D7Q34277926-25F88B2B-8BC2-4DD2-8255-EBCEA13202C1Q34479280-984ED694-BBA2-46C9-8BF8-24AFB495BA97Q34549406-3BF45B12-725B-4CD0-A16F-34107EA8BFE9Q34573211-63B7FB1E-A384-487D-9EB1-16CB13EB7F43Q35072261-499946CF-AFD5-4053-876E-92EB890D77D8Q35572161-C2EDADD6-3F4F-4ABD-96CE-8BDF3D3CA206Q35683435-E34E0CBA-7C59-4016-87B9-C8D4063A406BQ35744820-C1A51475-6ECD-4746-8D0D-467249ADFAC8Q36101677-91BB5523-940A-43B0-871F-CA7D02D2D109Q36153628-ABAAC763-D365-4D08-BA2F-984925F87657Q36278264-A3353731-259A-43BC-86E0-4CD1FE0E6897Q37088975-D49426DF-3B19-419F-AA12-C6BD58ADC68FQ37658639-5F2CB7F2-CEDF-4108-A32F-EF2B549DB706Q37834142-EA9C24C5-115F-408C-B7C7-E9C8B8DBECD4Q37987204-52048CE8-DEA4-4489-AB68-2EA809CAD00EQ38018680-FFA98D2F-CDFE-4499-9CCF-8F5E236B59CFQ38104388-CAA5C1C4-5C78-499D-85B6-974458E640EDQ38366274-ADD6D176-5E71-47C2-91BF-630F8BCA4B96Q38865456-697C4DD0-04E3-40A2-9756-B46367E3FBADQ40071378-02AE9424-68E4-4AF2-A4DD-AF01B0DFCE88Q41706384-2D6DD474-FADA-4FB9-9563-24203DEBD25AQ43800964-05B6DCD8-D693-4665-A3C8-A0975FEB1409Q50158774-FC7B488F-087D-4FAC-9AF9-A350845976CD
P2860
Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Use of proton pump inhibitors ...... tion-based case-control study.
@ast
Use of proton pump inhibitors ...... tion-based case-control study.
@en
Use of proton pump inhibitors ...... tion-based case-control study.
@nl
type
label
Use of proton pump inhibitors ...... tion-based case-control study.
@ast
Use of proton pump inhibitors ...... tion-based case-control study.
@en
Use of proton pump inhibitors ...... tion-based case-control study.
@nl
prefLabel
Use of proton pump inhibitors ...... tion-based case-control study.
@ast
Use of proton pump inhibitors ...... tion-based case-control study.
@en
Use of proton pump inhibitors ...... tion-based case-control study.
@nl
P2093
P2860
P356
P1476
Use of proton pump inhibitors ...... tion-based case-control study.
@en
P2093
Jennifer C Nelson
Lisa A Jackson
Michael L Jackson
Noel S Weiss
Rod L Walker
Sascha Dublin
P2860
P304
P356
10.1002/PDS.1978
P577
2010-08-01T00:00:00Z